Efficacy of Vonoprazan for Protonpump inhibitor resistant sleeping disorder caused by gastroesophageal reflux disease (GERD) symptoms.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2017
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 20 Mar 2017 Status changed from not yet recruiting to recruiting.
- 02 Jun 2016 New trial record